{
    "Trade/Device Name(s)": [
        "GLUCOLAB Auto-coding",
        "GLUCOLAB Auto-coding Blood Glucose Monitoring System",
        "GLUCOLAB Auto-coding Diabetes Monitoring System"
    ],
    "Submitter Information": "Infopia Co., Ltd.",
    "510(k) Number": "K091157",
    "Predicate Device Reference 510(k) Number(s)": [
        "K051285"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "October 23, 2009",
    "Summary Letter Received Date": "October 27, 2009",
    "Submission Date": "April 17, 2009",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "GLUCOLAB Auto-coding Blood Glucose Monitoring System meter"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test strip",
        "Control",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for GLUCOLAB Auto-coding Blood Glucose Monitoring System for quantitative whole blood glucose measurement with auto-coding functionality.",
    "Indications for Use Summary": "For quantitative measurement of glucose in whole blood to aid in diabetes management in home and clinical settings (excluding neonates), supporting alternate site testing; controls verify system performance.",
    "fda_folder": "Clinical Chemistry"
}